Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00148239 · ClinicalTrials.gov registry record · Phase 2
Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury
A Phase 2 study, sponsored by University of Pittsburgh.
- Completed
- Registry status
- Phase 2
- Development phase
- 380
- Enrollment target
NCT00148239: Completed Phase 2 study, sponsored by University of Pittsburgh.
NCT00148239 is a Phase 2 study that has completed, run by University of Pittsburgh. The registered enrollment target is 380 participants, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (186% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00148239, a Phase 2 study, has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 380 participants
- Enrollment target
Study Summary
The overall objective of this project is to test the efficacy of an innovative multi-component intervention aimed at reducing the risk for adverse health outcomes among caregivers of older survivors with spinal cord injury or disability, and to improve the well being of the spinal cord-injured survivor. In a three-group, randomized, controlled design providing access to information, resources, and support, we predict that the dual target approach will have a greater positive impact on both the caregiver and survivor than the caregiver-only approach, and that both active treatments will be superior with respect to caregiver outcomes than an information-only control condition.
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Caregiver Only Intervention
- BEHAVIORAL Dual Treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 380 participants |
| Start Date | 2002-09 |
| Est. Completion | 2008-07 |
| Phase | Phase 2 |
What the finished NCT00148239 record still lists
NCT00148239 is an interventional study that assigns participants to a tested intervention. The registered 380 participants enrollment target is mid-sized for trials with a published cap, above the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (186% higher).
The record links to 0 conditions, and to 3 interventions - of which Control is the first listed.
NCT00148239 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00148239 about?
NCT00148239 is a clinical study titled "Health Interventions for Survivors and Primary Support Persons of Spinal Cord Injury". The overall objective of this project is to test the efficacy of an innovative multi-component intervention aimed at reducing the risk for adverse health outcomes among caregivers of older survivors with spinal cord injury or disability, and to improve the well being of the spinal cord-injured survi...
What is the current status of trial NCT00148239?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 380 participants. The study started on 2002-09. Estimated completion is 2008-07.
What interventions are being tested in trial NCT00148239?
The interventions under investigation include: Control (BEHAVIORAL), Caregiver Only Intervention (BEHAVIORAL), Dual Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT00148239?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00148239's enrollment target sits among peer trials
380 111th of 2000 higher than 1,886 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04560673 · 380 participants · Phase 2
Duloxetine and Neurofeedback Training for the Treatment of Chemotherapy Induced Peripheral Neuropathy
- NCT04777357 · 380 participants · Phase 3
A Study to Assess Change in Disease Activity and Adverse Events (AEs) With Cariprazine in the Treatment of Depressive Episodes in Pediatric Participants Participants (10 to 17 Years of Age) With Bipolar I Disorder.
- NCT04821154 · 380 participants
Persona Revision Knee System Outcomes
- NCT05102019 · 380 participants · NA
Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia